Autophagy induction by starvation and stress involves the enzymatic activation of the class III phosphatidylinositol 3-kinase complex I (PI3KC3-C1). The inactive basal state of PI3KC3-C1 is maintained by inhibitory contacts between the VPS15 protein kinase and VPS34 lipid kinase domains that restrict the conformation of the VPS34 activation loop. Here, the pro-autophagic MIT domain-containing protein NRBF2 was used to map the structural changes leading to activation. Cryo-EM was used to visualize stepwise PI3KC3-C1 activating effects of binding the NRFB2 MIT domains. Binding of a single NRBF2 MIT domain to bends the helical solenoid of the VPS15 scaffold, displaces the protein kinase domain of VPS15, and releases the VPS34 kinase domain from the inhibited conformation. Binding of a second MIT stabilizes the VPS34 lipid kinase domain in an active conformation that has an unrestricted activation loop and is poised for access to membranes.
among other kinases (3) . PI3KC3-C1 is inhibited by anti-apoptotic proteins Bcl-2/Bcl-XL (10) .
The binding of Bcl-2/Bcl-XL and the best-characterized phosphoregulatory modulations of PI3KC3-C1 map to the base of the V. Thus far, the structural mechanisms of the many PI3KC3 regulators acting at the base of the V have been undefined.
Nuclear Receptor Binding Factor 2 (NRBF2) is a positive regulator of PI3KC3-C1 that also acts at the base of the V shape (17) . NRBF2 was identified as a PI3KC3-C1 associated factor through proteomics of the mammalian autophagy network (18) . Depletion of NRBF2 reduced autophagosome formation, implicating NRBF2 as pro-autophagic (18) . Work in S. cerevisiae identified Atg38 as the homolog of NRBF2 and confirmed Atg38 to be a proautophagic component of PI3KC3-C1 (19) . The pro-autophagic function of NRBF2 has been confirmed by most reports in mammalian cells (20) (21) (22) (23) (24) , although contrary findings were reported by one group (24) . NRBF2 and its ortholog Atg38 contain an N-terminal Microtubule Interacting and Trafficking (MIT) domain that binds to PI3KC3-C1, followed by a central dimeric coiledcoil domain (17, 19, 25) (Fig. 1B) . Dimerization can be decoupled from activation, as the Nterminal MIT domain (NRBF2 MIT ) alone is sufficient to enhance the kinase activity of the autophagy specific PI3-Kinase in vitro (17) and to rescue autophagy induction in MEFs (21) .
Here, we used cryo-EM and allied methods to show how NRBF2 allosterically activates PI3KC3-C1 at a structural and mechanistic level.
Results

Characterization of PI3KC3-C1 containing a NRBF2-MIT-BECN1 fusion construct
We had previously found that (1) the isolated NRBF2 MIT was sufficient to activate PI3KC3-C1, and (2) that the principal binding site of NRBF2 MIT included the N-terminal domain of BECN1 (17) . In order to generate a non-dissociable NRBF2 MIT complex with PI3KC3-C1 for cryo-EM studies, we built on these observations by fusing NRBF2 MIT to the N-terminus of BECN1 using a flexible (Gly-Gly-Ser) 4 linker (Fig. S1A, B ). To confirm that the MIT-linker construct occupies the same binding site within PI3KC3-C1 as unfused NRBF2, we purified a variant PI3KC3-C1 in which wild-type BECN1 was replaced by NRBF2 MIT -BECN1 ("MIT-Fusion"), performed HDX-MS, and compared the HDX protection of the NRBF2 complex to the fusion. In both cases, the reference was taken as wild-type PI3KC3-C1 in the absence of NRBF2 (Fig. S1C ).
We observed protection patterns in VPS34 ( Peptides within the N-terminal domains of BECN1 and ATG14, the VPS15 helical solenoid, and the VPS34 C2 domain showed HDX decreases of up to 50%. However, most HDX decreases throughout the remainder of the four subunits did not exceed ~10 %. In the NRBF2-BECN1 fusion complex, the regions that showed the highest protection were typically even more protected (Fig S1D-G) . Two regions of ATG14 that were ~15% protected in the NRBF2 complex with ~30% protected in the fusion, for example ( Fig. S1F) . Therefore, the presence of the fused NRBF2 MIT generally recapitulates the qualitative protection pattern seen in the noncovalent complex with intact NRBF2, but the degree of protection is greater. This is presumably because the fused complex cannot dissociate when it is diluted into D 2 O for exchange experiments. Outside of the regions expected to interact with NRBF2, increased protection was also noted. For example, most of the catalytic domains of VPS34 and VPS15 manifested a ~20% increase in protection in the fusion (Fig. S1D, G) . These increases are suggestive of a more global decrease in protein dynamics in the fused construct.
Cryo-EM structure of the BECN1-MIT-Fusion Complex
Previous EM analyses of PI3KC3s have been limited by the dynamic character of these complexes and by their tendency to be in preferred orientations on EM grids (11, 17, 25, 26) .
Even when preferred orientations can be reduced or eliminated, the dynamics of the catalytic right arm of the complex (27) has still limited analysis (14) . The apparent reduction in dynamics in the BECN1-NRBF2 MIT form of PI3KC3-C1 suggested that this sample might be more tractable to cryo-EM than the wild-type PI3KC3-C1 and -C2 complexes. Two-dimensional class averages of BECN1-NRBF2 MIT PI3KC3-C1 showed additional features compared to wild-type PI3KC3-C1 ( Fig. 1C , D). A reconstruction was obtained with an overall resolution of 7.7 Å and local resolution ranging from 6.7-24 Å ( Fig. 1E , F, Fig. S2 , Table S1 ), showing the expected Vshaped architecture. Atomic coordinates were modeled taking the crystal structures of yeast PI3KC3-C2 (12) and the NRBF2 MIT (RCSB entry 4ZEY) as the starting point ( Fig. 1E ). Density for the catalytic domains at the tip of the right arm is less defined than for the rest of the structure, however the density was clear enough to show that the VPS15 kinase is displaced relative to its position in the yeast PI3KC3-C2 structure. Despite the lack of side-chain definition at the attained resolution, it was possible to dock the NRBF2 MIT into density unambiguously on the basis of the unequal lengths of the three MIT helices.
The NRBF2 MIT is localized near the base of the right arm, on the back side of the complex in the standard view (Fig. 1E ). The extended contacts seen with multiple subunits are consistent with the high affinity (40 nM) of NRBF2 for PI3KC3-C1 (17) . The MIT interacts extensively with the central part of the VPS15 helical solenoid. The MIT also interacts with a helical density associated with the N-terminal portions of BECN1 and ATG14 ( Fig. 1E ). On the basis of its high HDX protection ( Fig. S1E ), this helix was provisionally assigned as the BH3 domain of BECN1. This region has not previously been visualized in any of the PI3KC3 structures, and it therefore appears to become ordered only in the presence of NRBF2 MIT . This helix in turn interacts with the most N-terminal portions of the parallel BECN1 and ATG14 coiled coils ( Fig. 1E ).
Activation requires NRBF2 MIT binding at two sites
The isolated NRBF2 MIT domain, added at a 60-fold molar excess to PI3KC3-C1, enhanced lipid kinase activity to the same degree as the full-length dimeric NRBF2 ( Fig. 2A ) (17) . Given that observation and the apparent full occupancy of the MIT binding site in the cryo-EM structure, we had expected that the BECN1-NRBF2 MIT fusion C1 complex would also have enhanced activity. Contrary to expectations, the BECN1-NRBF2 MIT fusion C1 complex had essentially the same activity as the C1 complex in the absence of NRBF2 ( Fig. 2A ). Addition of NRBF2 MIT to the BECN1-NRBF2 MIT fusion C1 complex enhanced activity to a similar extent as for the wildtype complex ( Fig. 2A ). We interpret this to mean that activation of PI3KC3-C1 by NRBF2 requires NRBF2 MIT to engage with at least two distinct binding sites on PI3KC3-C1.
In order to directly test the existence of a second MIT binding site, negative stain (NS) EM was carried out for the BECN1-NRBF2 MIT fusion C1 in the presence of a maltose binding protein (MBP) -tagged-NRBF2 MIT construct. Two-dimensional class averages of NS-EM images showed that a second copy of NRBF2 MIT binds to the MIT-Fusion complex as shown by the extra density for the MBP-tagged-NRBF2 MIT (Fig. 2B ). This extra density is located at the base of the complex near the first binding site, suggesting that both N-terminal MIT domains of a single full-length dimeric NRBF2 can occupy both sites simultaneously. These data suggest that the second binding site is lower affinity than the first, and that both binding sites are required for enzymatic activation.
Cryo-EM structure of full-length NRBF2 bound to PI3KC3-C1
A cryo-EM dataset was obtained for PI3KC3-C1 bound to full-length NRBF2. Two-dimensional class averages showed additional ordered features at the base of the complex and on the right arm as compared to the MIT fusion ( Fig. 2C ). Single particle reconstruction was carried out to an overall resolution of 6.6 Å ( Fig. 3A -E, S3, Table S1), with local resolution ranging from 5.4 to 18 Å (Fig. 3F ). The position of the first NRBF2 MIT is essentially identical to that seen in the MIT fusion. The local resolution of the NRBF2 MIT is improved, enabling the MIT three-helix bundle to be placed with greater precision ( Fig. 3C -E). The structure shows the N-terminus of MIT α1, the α2-α3 connector, and the length of α3 of NRBF2 MIT with helices α12, α14, and α16 of the VPS15 solenoid ( Fig. 3E ).
The VPS34 kinase domain in the NRBF2 complex is better ordered than in the MIT fusion, the main point of difference between the two. The VPS34 kinase is still the least welldefined part of the structure, however, as measured by local resolution (Fig. 3F ). Although most of the kinase domain is at ~8 Å resolution ( Fig. 3F ), the most distal portions are as low as 18 Å resolution. Despite indications of additional features and what appears to be the coiled-coil stalk of dimeric NRBF2 projecting away from the right arm in the 2D class averages ( Fig. 2C) , it was not possible to assign the locations of these moieties definitively to the density features at the periphery of the VPS34 kinase domain. We infer that the second NRBF2 MIT is bound to this relatively flexible region, and it is not surprising that small domains associated with mobile portions of a complex would not be evident.
Comparison to inactive conformation of PI3KC3-C2
In the yeast crystal structure, the VPS15 kinase domain contacts the activation loop of VPS34 such that VPS15 inhibits basal VPS34 activity (12) ( Fig These changes separate the two domains so that the gap between the most C-terminal ordered residue of VPS34 and the N-terminal residue of VPS15 increases from 28 to 51 Å ( Fig. 4C , D).
This change completely liberates the VPS34 kinase activation loop seen in the inactive structure.
Discussion
The ultimate goal of structural studies of PI3KC3 complex is to understand how they are switched on and off in autophagy by phosphoregulation and by binding of regulatory factors such as Bcl-2, Ambra1, Rubicon, and NRBF2. The structure of one PI3KC3 complex, yeast PI3KC3-C2, has been determined in an inactive conformation (12) . The kinase domain of VPS15 keeps basal activity low by restricting the activation loop of VPS34 (12) . Our laboratory previously found that the VPS34 kinase domain is highly dynamic (11, 27) . We found that "leashing" the VPS34 kinase domain to the VPS15 kinase domain with a 12-residue linker blocked even basal kinase activity (Stjepanovic et al., 2017) . This showed that a substantial structural change relative to the published PI3KC3-C2 conformation was essential for any activity, yet the precise nature of the structural change was not clear. The structural change here involves an increase in the VPS34-C to VPS15-N gap from 28 to 51 Å. The increase in distance on activation is great enough that it would be prevented by a 12-amino acid linker. The structural change observed here is thus sufficient to account for the phenotype of the leashed construct.
NRBF2 was chosen as the model allosteric regulator of PI3KC3 in this study because it is one of the well-established protein activators of PI3KC3-C1. By using NRBF2 as a structural probe, it has now been possible to visualize conformational changes likely to be associated with multiple regulatory mechanisms. The base of the complex, near the first MIT binding site, is where a number of post-translational and regulatory signals converge on the autophagic specific PI3KC3-C1 via the regulatory hub, the N-termini of BECN1 and ATG14 (3). This is the site that is modulated by ULK1, AMPK, and Bcl-2, among prominent positive and negative regulators. A single ordered helix is visualized bound to NRBF2 MIT which we provisionally assigned as the BECN1 BH3 domain, because the BH3 domain is the portion of BECN1 which is most protected from HDX upon NRBF2 binding. The BH3 is also the binding site for the PI3KC3 inhibitor Bcl-2, suggesting there could be some interplay between regulation by Bcl-2 and NRBF2. The Full length NRBF2 can dimerize of PI3KC3-C1, forming a dimer of pentamers (17, 25) , while full length Atg38 does not show this dimerizing effect with respect to yeast PI3KC3-C1 (25) . We previously hypothesized that full-length NRBF2 could tether two copies of PI3KC3-C1 within the cell, perhaps facilitating vesicle tethering or membrane binding interactions. The finding that two copies of NRBF2 MIT are necessary for full PI3KC3-C1 activation argues that the activating mode of binding is probably one NRBF2 dimer per PI3KC3-C1 complex, which is incompatible with the C1 dimerization model. NRBF2 (and yeast Atg38) are specific for PI3KC3-C1, and thus specific for autophagy initiation. Our previous HDX-MS work and the cryo-EM work shown here, however, did not show evidence of direct contacts with the C1-unique subunit ATG14. The position of the NRBF2 MIT overlaps with the UVRAG C2 domain in the structure (Fig. S4 ). This suggests that the presence of the UVRAG C2 domain is a main factor preventing NRBF2 from binding to PI3KC3-C2.
PI3KC3 complex structures have now been determined with the VPS34 catalytic domain in stable active and inactive conformations. The VPS34 catalytic domain is also capable of dislodging from the rest of the complex and sampling a wide range of conformations (11) . We speculate that dislodging could facilitate the transition between the active and inactive conformations. The activity of the dislodged state appears to be intermediate between that of the stable inactive and active states ( Fig. 4E ). As judged by the phenotype of the leashed complex (27) , the stable inactive conformation has almost no enzyme activity. The activity of the dislodged state seems likely to reflect that of the isolated VPS34 kinase domain, which is about ~10% of that of PI3KC3-C1 (27) . The presence of a single NRBF2 MIT domain appears sufficient to block the stable inactive conformation, but insufficient to drive full occupancy of the stable active conformation. By contrast, both MIT domains together not only block the stable inactive conformation, they also promote high occupancy of the stable active structure. In this structure, not only are the catalytic site, the C-terminal membrane binding helix, and the activation loop of VPS34 unrestricted, but they are also presented to the membrane substrate with an ideal geometry for PI headgroup phosphorylation.
Materials and methods
Purification of NRBF2 and NRBF2 MIT
The full length DNA encoding NRBF2 was cloned into vectors 1M (Addgene #29565), 
Purification of PI3KC3-C1 and MIT-Fusion
The full length DNAs encoding VPS15, VPS34, and BECN1 were codon optimized for expression in HEK293 cells as previously described (11) . Full length ATG14 was cloned into a pCAG vector with GST-tag and used for kinase assays. A truncation of ATG14 lacking the last ATG14 ∆ALPS ) and used for HDX-MS, EM, and SEC studies. Inhibitory phosphorylation sites occur at serines 113 and 120 in NRBF2 (23) . These sites were mutated to phosphonulls, creating S113A and S120A. The MIT-linker-BECN1 construct was then generated by amplifying residues 1-159 of NRBF2 including S113A and S120A with an overlapping linker sequence and performing two-step polymerase chain reaction with BECN1 and moved into vector 6A obtained 
Electron microscopy sample preparation
Negatively stained samples of PI3KC3-C1 and PI3KC3-C1:MBP-NRBF2 MIT were prepared on continuous carbon grids that had been plasma cleaned in a 10% O2 atmosphere for 10 s using a Gauting, Germany) using the automated Leginon data collection software (28) . Defocus was randomized between -1.3 to -3.3 microns. SerialEM was used to collect an automated dataset of micrographs.
Cryo-EM sample preparation and data acquisition
Cryo-EM image processing
One dataset of apo PI3KC3-C1 was collected and processed. Two different datasets of MIT-Fusion were collected, but initially processed separately until 3D refinement. Image stacks were corrected for drift using MotionCor2 (29) and dose-weighted within FOCUS. Contrast transfer functions (CTF) were estimated per micrograph with GCTF and reference-free particle picking was performed on the PI3KC3-C1 dataset and the first dataset of MIT-Fusion using gautomatch (K. Zhang, MRC-LMB, Cambridge). Particles were extracted in Relion-3.0 (30) with box size 352 2 , binned 8-fold. After 2D classification, particles from protein-containing classes were unbinned and used for ab-initio modelling in cryosparc (31) . The ab-initio models of PI3KC3-C1 and MIT-Fusion were re-imported, refined in Relion and re-classified in 2D. Upon manual inspection of the severely anisotropic 3D reconstruction, it was decided to stop processing the PI3KC3-C1 dataset. For the MIT-Fusion dataset, six class averages were selected as templates for reference-based particle picking with gautomatch on micrographs from both datasets.
Particles were cleaned up in several rounds of 2D classification, leaving 243,176 and 464,778 particles from the first and second dataset, respectively. The particles from the first dataset were used to build an ab-initio model in Cryosparc-v0.6.5. This model was subsequently refined in Relion using a reference low-pass-filtered to 60 Å, to remove high resolution features which might bias the reconstruction. Masks were created based on the refined map within Relion.
Particles were separated into five classes using 3D classification with angular sampling of 7.5° and a mask masking out the kinase domain ( Figure S2 ). The 43,089 particles in the best class were combined with the 464,778 particles from the second dataset. Particles were then separated into three classes using 3D classification without angular sampling and the best class (74,303 particles) was refined. 3D classification was repeated with angular sampling of 7.5° on the refined map using a mask and refinement was performed on the best class (45,236 particles).
A dataset of 2NRBF2:PI3KC3-C1 was collected (1700 micrographs) and processed within RELION 3.0.4 (30) using MotionCor2 (29) and GCTF (32) with box size 352 2 , binned 8-fold.
After 2D classification, particles from protein-containing classes were unbinned and used as references within RELION for automated particle picking. The resulting 1e6 particles were cleaned up and an ab-initio model was generated in CryoSparc (31) . The ab-initio model and the particle stack containing the initial angles from CryoSparc were imported and then refined in RELION first, without a mask (10 Å map) and then with a mask (6.9 Å). Three classification was performed on the 251,100 particles and the particles with the best density for VPS34 were selected. These particles were refined and then subjected to a signal subtraction procedure in which the core solenoid was the region of interest for further alignment, as this is the best region of the map with the least heterogeneity, allowing for an effective signal subtraction step. The core was then subjected to 3D classification without angular sampling and the resulting 86,218 particles were further refined to 6.6 Å and a b-factor of -254 Å 2 .
CryoEM Modeling
Coordinates were docked into the MIT-Fusion cryoEM reconstruction using homology models from yeast PI3KC3-C2 (PDB: 5DFZ), coordinates from human NRBF2 MIT PI3KC3-C1 is highly dynamic, and the VPS34 kinase domain can dislodge (light pink) from the complex to directly bind membranes without the benefit of the rest of the complex. In the activated state, VPS34 is positioned in a precise geometry such that the activation loop of VPS34 is accessible to substrate in the membrane. 
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